Kenichiro Asano
7PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 24, 2026
Dynamics of MGMT Methylation Status in Malignant Gliomas With and Without Therapeutic Intervention: Significance of Two-Dimensional Immunohistochemical Analysis and Evaluation of Recurrent Specimens.Kenichiro Asano, Toshio Fumoto, Akihisa Kamataki
|Mar 21, 2022
Clinicopathological risk factors for a poor prognosis of primary central nervous system lymphoma in elderly patients in the Tohoku and Niigata area: a multicenter, retrospective, cohort study of the Tohoku Brain Tumor Study Group.Kenichiro Asano, Yoji Yamashita, Takahiro Ono
|Oct 12, 2021
The Real-World status and risk factors for a poor prognosis in elderly patients with primary central nervous system malignant lymphomas: a multicenter, retrospective cohort study of the Tohoku Brain Tumor Study Group.Kenichiro Asano, Yoji Yamashita, Takahiro Ono
|Jul 29, 2021
Combination chemoradiotherapy with temozolomide, vincristine, and interferon-β might improve outcomes regardless of O6-methyl-guanine-DNA-methyltransferase (MGMT) promoter methylation status in newly glioblastoma.Kenichiro Asano, Toshio Fumoto, Masashi Matsuzaka
|Jun 28, 2018
Importance and accuracy of intraoperative frozen section diagnosis of the resection margin for effective carmustine wafer implantation.Kenichiro Asano, Akira Kurose, Akihisa Kamataki
Pageof 2
